Peleteiro B et al. – This is the first study to use CDX2 expression as a finer marker of intestinal differentiation to distinguish aetiologically distinct subgroups of gastric cancer, adding new evidence to the previous research on the determinants of cancer of Lauren’s intestinal and diffuse types.
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor